Does METOPROLOL Cause Interstitial lung disease? 74 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Interstitial lung disease have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.2% of all adverse event reports for METOPROLOL.
74
Reports of Interstitial lung disease with METOPROLOL
0.2%
of all METOPROLOL reports
10
Deaths
46
Hospitalizations
How Dangerous Is Interstitial lung disease From METOPROLOL?
Of the 74 reports, 10 (13.5%) resulted in death, 46 (62.2%) required hospitalization, and 13 (17.6%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which METOPROLOL Alternatives Have Lower Interstitial lung disease Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE